Single‐dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate‐release and hydrophilic matrix extended‐release tablets in healthy Japanese subjects without co‐administration of an opioid antagonist

Publisher: John Wiley & Sons Inc

E-ISSN: 1552-4604|55|9|975-984

ISSN: 0091-2700

Source: JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.9, 2015-09, pp. : 975-984

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content